Japanese Criteria of Metabolic Syndrome

To the Editor:
We appreciate the labor-some quadratic regression analyses by Dr Matsuzawa. 1 However, we are afraid that our intention was not properly conveyed to the author. He stated in Author's Reply to our letter 1 that there were minor differences between quadratic and linear regression analyses in order to determine the optimal cut-points of waist circumference (WC) to discriminate persons with visceral fat area (VFA) ≥100 cm 2 from those with VFA <100 cm 2 and that the Japanese cut-points of WC 2 are the only ones supported by evidence. 1 However, he mentioned neither receiver operating characteristic (ROC) curves, nor areas under ROC curves (AUC). If he did ROC and AUC analyses, WC might be revealed as a poor discriminator of VFA especially in women, even if these 2 factors are well correlated. After all, WC is a marker of abdominal (central) obesity, not of visceral obesity (which is assessed by VFA using CT scanning, exposing subjects to irradiation). At least he should reveal the sensitivities and specificities of the cut-points of WC as a discriminator of VFA. Without his revelation, one can easily see in his VFA-WC distribution graphs 2 that the sensitivity of the female cut-point of 90 cm is less than 50%. Furthermore, he did not separately analyze the optimal cut-points of VFA by gender. If he did so, the optimal cut-point of VFA for women might be lower than that for men, because more abundant subcutaneous fat in women than in men may also contribute to multiple risk factors, even if the degree of the contribution is less than that of visceral fat. Therefore, this female cut-point of WC (90 cm) is not acceptable.
Regarding criteria of metabolic syndrome, the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) criteria 3 stand on the concept of a syndrome resulting from multiple causes, the International Diabetes Federation (IDF) criteria 4 stand on the concept of an entity due to central obesity, and the Japanese criteria 5 intended to, but do not really, stand on the concept of an entity due to visceral obesity, and excluded women with HDL cholesterol levels of 40-49 mg/dl, which constitutes a significant risk category for both coronary events and total mortality in Japan. 6 The American Diabetes Association/ European Association for the Study of Diabetes jointly stated that doctors should not label patients with metabolic syndrome because the concept is premature as a syndrome. And Reaven called off debating the pros and cons of various definitions of metabolic syndrome. 8 Nevertheless, no one can stop endless debates upon new definitions of it 9-12 except in Japan where the Japanese criteria 5 was forced upon people ex cathedra. Therefore, we wish the Examination Committee of Criteria for Metabolic Syndrome would withdraw their unique Japanese criteria of metabolic syndrome 5 based on no prospective prognostic evidence and really cooperate internationally. At least one should understand that this Japanese definition is not the only one based on prospective prognostic evidence, but one of many arbitrary premature definitions 7 and the concept of which differs from those of 2 recently published worldwide AHA/NHLBI 3 and IDF 4 definitions, thus hindering global cooperation, contrary to the intention of the Committee. 5 
